FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Deeg

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Disorders

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Mark A Deeg; George Eckert; Ying Grace Li; Robert V Considine; Xiaoling Xuei; J Howard Pratt
Genetic variation of GPLD1 associates with serum GPI-PLD levels: a preliminary study.
Nandita S Raikwar; Rosario F Bowen-Deeg; X Sean Du; Martin G Low; Mark A Deeg
Glycosylphosphatidylinositol-specific phospholipase D improves glucose tolerance.
Dona L Gray; Kevin D O'Brien; David A D'Alessio; Bonnie J Brehm; Mark A Deeg
Plasma glycosylphosphatidylinositol-specific phospholipase D predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese women.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Deeg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mark A Deeg; George Eckert; Ying Grace Li; Robert V Considine; Xiaoling Xuei; J Howard Pratt
Genetic variation of GPLD1 associates with serum GPI-PLD levels: a preliminary study.
Biochimica et biophysica acta 2012;1821(3):381-5.
2010: Nandita S Raikwar; Rosario F Bowen-Deeg; X Sean Du; Martin G Low; Mark A Deeg
Glycosylphosphatidylinositol-specific phospholipase D improves glucose tolerance.
Metabolism: clinical and experimental 2010;59(10):1413-20.
2008: Dona L Gray; Kevin D O'Brien; David A D'Alessio; Bonnie J Brehm; Mark A Deeg
Plasma glycosylphosphatidylinositol-specific phospholipase D predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese women.
Metabolism: clinical and experimental 2008;57(4):473-8.
2007: Steven J Miller; William C Watson; Kimberly A Kerr; Carlos A Labarrere; Neal X Chen; Mark A Deeg; Joseph Unthank
Development of progressive aortic vasculopathy in a rat model of aging.
American journal of physiology. Heart and circulatory physiology 2007;293(5):H2634-43.
2007: Mark A Deeg; Nandita S Raikwar; Cynthia Johnson; Craig D Williams
Statin therapy reduces serum levels of glycosylphosphatidylinositol-specific phospholipase D.
Translational research : the journal of laboratory and clinical medicine 2007;150(3):153-7.
2007: Mark A Deeg; Sindhu Jacob; Jianzhao Shen; David G Marrero
Primary care physician treatment of low HDL: Rational approach or Pandora's Box?
Journal of clinical lipidology 2007;1(3):198-202.
2006: Naga Chalasani; Raj Vuppalanchi; Nandita S Raikwar; Mark A Deeg
Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.
The Journal of clinical endocrinology and metabolism 2006;91(6):2279-85.
2006: Nandita S Raikwar; Won Kyoo Cho; Rosario F Bowen; Mark A Deeg
Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.
American journal of physiology. Endocrinology and metabolism 2006;290(3):E463-70.
2006: Michael P Dubé; Julia W Wu; Judith A Aberg; Mark A Deeg; Beverly Alston-Smith; Mark E McGovern; Daniel Lee; Sharon L Shriver; Ana I Martinez; Martha Greenwald; James H Stein
Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148.
Antiviral therapy 2006;11(8):1081-9.
2005: Nandita S Raikwar; Rosario F Bowen; Mark A Deeg
Mutating His29, His125, His133 or His158 abolishes glycosylphosphatidylinositol-specific phospholipase D catalytic activity.
The Biochemical journal 2005;391(Pt 2):285-9.
2005: Mark A Deeg
Basic approach to managing hyperglycemia for the nonendocrinologist.
The American journal of cardiology 2005;96(4A):37E-40E.
2004: Naga Chalasani; Mark A Deeg; David W Crabb
Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.
The American journal of gastroenterology 2004;99(8):1497-502.
2004: D M Larson; M A Kennedy; Rosario F Bowen; C B Verchere; Mark A Deeg
Glycosylphosphatidylinositol-specific phospholipase D immunoreactivity is present in islet amyloid in type 2 diabetes.
The Journal of pathology 2004;203(4):961-7.
2004: Karl J Mann; Matthew R Hepworth; Nandita S Raikwar; Mark A Deeg; Daniel Sevlever
Effect of glycosylphosphatidylinositol (GPI)-phospholipase D overexpression on GPI metabolism.
The Biochemical journal 2004;378(Pt 2):641-8.
2004: Trisha A Kurtz; Naomi S Fineberg; Robert V Considine; Mark A Deeg
Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D.
Metabolism: clinical and experimental 2004;53(2):138-9.
2004: Erika M Young; Robert V Considine; Fred R Sattler; Mark A Deeg; Thomas A Buchanan; Mikako Degawa-Yamauchi; Sudha Shankar; Hannah Edmondson-Melançon; Jaime Hernandez; Michael P Dubé
Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy.
Cardiovascular toxicology 2004;4(2):179-86.
2003: Mark A Deeg
Dietary cholate is required for antiatherogenic effects of ethanol in mouse models.
Alcoholism, clinical and experimental research 2003;27(9):1499-506.
2003: Naga Chalasani; Mark A Deeg; Scott Persohn; David W Crabb
Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.
The American journal of gastroenterology 2003;98(8):1849-55.
2002: Min You; Monika Fischer; Mark A Deeg; David W Crabb
Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP).
The Journal of biological chemistry 2002;277(32):29342-7.
2002: Mark A Deeg; Rosario F Bowen
Phosphorylation decreases trypsin activation and apolipoprotein al binding to glycosylphosphatidylinositol-specific phospholipase D.
Biochemistry and cell biology = Biochimie et biologie cellulaire 2002;80(2):253-60.
2001: Rosario F Bowen; Nandita S Raikwar; LK Olson; Mark A Deeg
Glucose and insulin regulate glycosylphosphatidylinositol-specific phospholipase D expression in islet beta cells.
Metabolism: clinical and experimental 2001;50(12):1489-92.
2001: Mark A Deeg; Rosario F Bowen; M D Williams; LK Olson; Elizabeth A Kirk; Renée C LeBoeuf
Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes.
American journal of physiology. Endocrinology and metabolism 2001;281(1):E147-54.
2001: Mark A Deeg; EL Bierman; M C Cheung
GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex.
Journal of lipid research 2001;42(3):442-51.
1999: Mark A Deeg; Rosario F Bowen
Midportion antibodies stimulate glycosylphosphatidylinositol-specific phospholipase D activity.
Archives of biochemistry and biophysics 1999;370(2):278-84.
1999: Kevin D O'Brien; C Pineda; W S Chiu; R Bowen; Mark A Deeg
Glycosylphosphatidylinositol-specific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes.
Circulation 1999;99(22):2876-82.
1998: Renée C LeBoeuf; M Caldwell; Yong Guo; C Metz; M A Davitz; LK Olson; Mark A Deeg
Mouse glycosylphosphatidylinositol-specific phospholipase D (Gpld1) characterization.
Mammalian genome : official journal of the International Mammalian Genome Society 1998;9(9):710-4.
1997: W S Garver; Mark A Deeg; Rosario F Bowen; M M Culala; EL Bierman; John F Oram
Phosphoproteins regulated by the interaction of high-density lipoprotein with human skin fibroblasts.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):2698-706.
1997: Mark A Deeg; Rosario F Bowen; John F Oram; EL Bierman
High density lipoproteins stimulate mitogen-activated protein kinases in human skin fibroblasts.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(9):1667-74.
1997: Mark A Deeg; C B Verchere
Regulation of glycosylphosphatidylinositol-specific phospholipase D secretion from beta TC3 cells.
Endocrinology 1997;138(2):819-26.
1996: Mark A Deeg; EW Lipkin
Hypoglycemia associated with the use of fluoxetine.
The Western journal of medicine 1996;164(3):262-3.
1995: Mark A Deeg; M A Davitz
Glycosylphosphatidylinositol-phospholipase D: a tool for glycosylphosphatidylinositol structural analysis.
Methods in enzymology 1995;250():630-40.
1994: Mark A Deeg
GPI-specific phospholipase D as an apolipoprotein.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 1994;27(2):375-81.